ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Assessment"

  • Abstract Number: 99 • 2017 ACR/ARHP Annual Meeting

    A Pilot Study of the Use of a Validated Gout Script Concordance Test Assessment in an Interdisciplinary Musculoskeletal Education Program

    Bernadette C. Siaton1, Andrea Barker2 and Michael J. Battistone2, 1Rheumatology, University of Maryland School of Medicine, Baltimore, MD, 2Veterans Affairs Salt Lake City Health Care System and University of Utah School of Medicine, Salt Lake City, UT

    Background/Purpose: A validated script concordance assessment (SCT) for gout was created for use in the internal medicine residency program at the University of Maryland Medical…
  • Abstract Number: 232 • 2017 ACR/ARHP Annual Meeting

    The Charla De Lupus (Lupus Chat)® Program: Assessing the Needs of Teens and Young Adults with Lupus and Their Caregivers to Develop a Family Model Nutrition and Fitness Intervention

    Melissa T. Flores1, Jillian Rose2, Priscilla Toral1, Lillian Mendez1, Dariana M. Pichardo1, Roberta Horton1 and Lisa F. Imundo3, 1Social Work Programs, Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, New York, NY, 3Pediatrics, Columbia University Medical Center, New York, NY

    Background/Purpose: Studies show Hispanics/Latinos are significantly impacted by health disparities, with higher rates of obesity & diabetes than Whites. Combined with SLE & higher risk…
  • Abstract Number: 344 • 2017 ACR/ARHP Annual Meeting

    Real World Clinical Trial Comparing the Patient Reported Outcomes Measurement Information System Short Forms and Profiles to CDAI Disease Classification in Rheumatoid Arthritis Patients

    Jeffrey R. Curtis1, Sergio Schwartzman2, Shelly Kafka3, Dennis Parenti3, Shawn Black3, Stephen Xu4, Wayne Langholff4 and Clifton O. Bingham III5, 1Rheumatology & Immunology, University of Alabama at Birmingham, Birmingham, AL, 2Weill Cornell Medical College, New York, NY, 3Janssen Scientific Affairs, LLC, Horsham, PA, 4Janssen Research & Development, LLC, Spring House, PA, 5Rheumatology, Johns Hopkins University, Baltimore, MD

    Background/Purpose: Patient (Pt) reported outcomes (PROs) play a role in overall disease evaluation, therapeutic response assessment and care of rheumatoid arthritis (RA) patients (Pts). The…
  • Abstract Number: 424 • 2017 ACR/ARHP Annual Meeting

    Re-Establishment of Efficacy of Tofacitinib, an Oral Janus Kinase Inhibitor, in Rheumatoid Arthritis Patients after Temporary Discontinuation

    Jeffrey Kaine1, John Tesser2, Ryan DeMasi3, Liza Takiya3, Lisy Wang4, Mark Snyder3, Haiyun Fan4 and Jürgen Wollenhaupt5, 1Sarasota Arthritis Research Center, Sarasota, FL, 2Arizona Arthritis & Rheumatology Associates, Glendale, AZ, 3Pfizer Inc, Collegeville, PA, 4Pfizer Inc, Groton, CT, 5Schön-Klinik Hamburg-Eilbek Teaching Hospital of the University of Hamburg, Hamburg, Germany

    Background/Purpose: Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). We assessed tofacitinib efficacy and safety after temporary discontinuation and…
  • Abstract Number: 1344 • 2017 ACR/ARHP Annual Meeting

    Impact of Fibromyalgic RA on Composite Scores; Results from a Longitudinal Study of RA Patients Initiating Bdmard Therapy

    Hilde B Hammer1, Sella A. Provan2, Brigitte Michelsen3, Till Uhlig4, Jon Lampa5 and Tore K Kvien6, 1Rheumatology, Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 2Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 3Rheumatology, Hospital of Southern Norway trust, Kristiansand, Norway, 4Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 5Karolinska Institute, Department of Medicine, Rheumatology Unit, Stockholm, Sweden, Stockholm, Sweden, 6On behalf of the NOR-DMARD registry, Oslo, Norway

    Background/Purpose: The composite scores DAS28, CDAI and SDAI all include number of tender and swollen joints (of 28). Rheumatoid arthritis (RA) patients with tender to…
  • Abstract Number: 1621 • 2017 ACR/ARHP Annual Meeting

    Prevalence of Cognitive Impairment in Systemic Lupus Erythematosus Assessed By the Automated Neuropsychological Assessment Metrics

    Zahi Touma1, Robin Green2, Lesley Ruttan3, Sabrina Lombardi3, Carmela Tartaglia4, Nicole Anderson5, Jiandong Su6, Kenneth Colosimo6, Michelle Vitti6, Dennisse Bonilla6, Joan E. Wither5, Marvin J. Fritzler7 and Dorcas Beaton8, 1Rheumatology, University of Toronto, Division of Rheumatology, Institute of Health Policy, Management and Evaluation, Toronto, ON, Canada, 2Brain and Therapeutics, Toronto Rehabilitation Institute, Toronto, ON, Canada, 3Toronto Rehabilitation Institute, Toronto, ON, Canada, 4University of Toronto, Krembil Neurosciences Centre, Toronto, ON, Canada, 5Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 6University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 7Medicine, University of Calgary, Calgary, AB, Canada, 8Mobility Program Clinical Research Unit, St Michael's Hospital, Toronto, ON, Canada

    Background/Purpose: The screening and diagnosis of Cognitive Impairment (CI) in Systemic Lupus Erythematosus (SLE) patients is often delayed. CI diagnosed according to the American College…
  • Abstract Number: 1870 • 2017 ACR/ARHP Annual Meeting

    Validation of an Electronic Version of the Michigan Body Map

    Chad M. Brummett1, David Kohns2, Rishi Bakshi3, Jenna Goesling4, Stephanie Moser1, Jennifer Pierce4, David Williams5, Daniel J. Clauw5, Afton L. Hassett1 and Erin Spencer2, 1Anesthesiology, University of Michigan, Ann Arbor, MI, 2University of Michigan, Ann Arbor, MI, 3Physical Medicine Rehabilitaion, Univeristy of Michigan, Ann Arbor, MI, 4Department of Anesthesiology, University of Michigan, Ann Arbor, MI, 5Chronic Pain & Fatigue Research Center, University of Michigan, Ann Arbor, MI

    Background/Purpose: We previously validated the Michigan Body Map (MBM) to accurately assess widespread body pain and as a means of administering the Widespread Pain Index…
  • Abstract Number: 2010 • 2017 ACR/ARHP Annual Meeting

    Does PET CT Matter in Assessing Extent of Disease in Relapsing Polychondritis – a Single Center Pilot Study

    Aman Sharma1, Adarsh MB2, Shankar Naidu3, Varun Dhir4, Roshan Verma5, Rajender Basher5, Anish Bhattacharya6, Sanjay Jain7 and B R Mittal6, 1Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India, 2Internal Medicine, PGIMER, Chandigarh, India, 3PGIMER, cHANDIGARH, India, 4Internal Medicine (Rheumatology Unit), Postgraduate Institute of Medical Education and Research, Chandigarh, India, 5PGIMER, Chandigarh, India, 6Nuclear Medicine, PGIMER, Chandigarh, India, 7PGIMER, CHANDIGARH, India

    Background/Purpose: Relapsing polychondritis(RP) is a rare rheumatic disease involving cartilaginous and proteoglycan rich structures. Clinical examination and radiological investigations have limitations in assessing the extent…
  • Abstract Number: 2141 • 2017 ACR/ARHP Annual Meeting

    Quantitative Nailfold Video Capillaroscopy Parameters Correlate with Dermatomyositis Activity and Damage

    Hans Prakash1, Diego Song1, Daniel Lichy1, Pranay Rao2, Mina Jain3, Joseph Shrader3, Frederick W Miller4, Adam Schiffenbauer5, Alexander Gorbach1 and Lisa G Rider5, 1National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD, 2National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, bethesda, MD, 3Rehabilitation Medicine Department, National Institutes of Health, Bethesda, MD, 4Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD, 5Environmental Autoimmunity Grp, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD

    Background/Purpose: To assess microvascular structure and function in patients with adult dermatomyositis (DM) and juvenile dermatomyositis (JDM), we have designed and built a mobile, high-resolution…
  • Abstract Number: 1134 • 2016 ACR/ARHP Annual Meeting

    Confidence and Competence of Medicine Trainees’ Musculoskeletal Skills: A Report of the Relationship from a Large Multi-Year, Multidisciplinary Cohort

    Andrea M. Barker1, Grant W. Cannon2 and Michael J. Battistone1, 1Veterans Affairs Salt Lake City Health Care System and University of Utah School of Medicine, Salt Lake City, UT, 2Internal Medicine, Veterans Affairs Salt Lake City Health Care System and University of Utah School of Medicine, Salt Lake City, UT

    Background/Purpose: The Musculoskeletal (MSK) Education Week for medical students, residents, fellows, and trainees of other health professions has been sustained since 2011. The objective of…
  • Abstract Number: 2750 • 2016 ACR/ARHP Annual Meeting

    Concordance Between Patient and Physician Global Assessment of the Disease in Patients with Psoriatic Arthritis

    Josefina Gallino Yanzi1, Osvaldo Luis Cerda2, Margarita Landi2, Cecilia Zaffarana2, Emilce Schneeberger2 and Gustavo Citera1, 1Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 2Rheumatology Section, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina

    Background/Purpose:  In Rheumatoid Arthritis it has been observed a significant discrepancy in the global assessment of the disease by the patient and physician and this…
  • Abstract Number: 3062 • 2016 ACR/ARHP Annual Meeting

    Use of Script Concordance Testing to Evaluate the Efficacy of a Web-Based Module on Gout: Three Years of Experience

    Bernadette C. Siaton1, Elizabeth Clayton2, Alexandra M. Kueider3 and Matthew Rietschel4, 1Rheumatology, University of Maryland School of Medicine, Baltimore, MD, 2Edmund J. MacLaughlin, M.D., L.L.C., Easton, MD, 3Laboratory of Behavioral Neuroscience -Unit of Clinical and Translational Neuroscience, National Institute on Aging, Baltimore, MD, 4University of Maryland School of Nursing, Baltimore, MD

    Background/Purpose: Despite the prevalence of musculoskeletal conditions, the majority of internal medicine trainees at the University of Maryland complete residency with little exposure to rheumatology…
  • Abstract Number: 3154 • 2016 ACR/ARHP Annual Meeting

    Assessing Bone Erosions in the Metatarsophalangeal Joints of Patients with Early Rheumatoid Arthritis:  a Comparison Between MRI and Ultrasound

    Karen A. Beattie1, Sydney Scheffler2, George Ioannidis3, Edward Schreyer4, Saara Totterman5 and Maggie Larche1, 1Medicine, McMaster University, Hamilton, ON, Canada, 2McMaster University, Hamilton, ON, Canada, 3St Joseph's Healthcare Hamilton, Hamilton, ON, Canada, 4QMetrics Technologies, Rochester, NY, 5Radiology, VirtualScopics Inc., Rochester, NY

    Background/Purpose: This cross-sectional study aimed to assess the agreement between Magnetic Resonance Imaging (MRI) and ultrasound (US) findings of bone erosions in the metatarsalphalangeal (MTP)…
  • Abstract Number: 3068 • 2015 ACR/ARHP Annual Meeting

    Damage Assessment in Takayasu’s Arteritis

    Antoine G. Sreih1, Tanaz A. Kermani2, David Cuthbertson3, Simon Carette4, Gary S. Hoffman5, Nader A. Khalidi6, Curry L. Koening7, Carol A. Langford5, Carol McAlear8, Paul A. Monach9, Larry W. Moreland10, Christian Pagnoux11, Philip Seo12, Kenneth J. Warrington13, Steven R. Ytterberg14 and Peter A. Merkel8, 1Department of Rheumatology, University of Pennsylvania, Philadelphia, PA, 2Rheumatology, University of California Los Angeles, Santa Monica, CA, 3Biostatistics and Informatics, Department of Pediatrics, University of South Florida, Tampa, FL, 4Division of Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, 5Rheumatology, Cleveland Clinic, Cleveland, OH, 6McMaster University, Hamilton, ON, Canada, 7Division of rheumatology, George E. Wahlen Department of Veterans Affairs Medical Center Salt Lake City and University of Utah, University of Utah School of Medicine, Salt Lake City, UT, 8Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, 9Section of Rheumatology, Vasculitis Center, Boston University School of Medicine, Boston, MA, 10Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 11Rheumatology, Division of Rheumatology, Mount Sinai Hospital, Toronto, ON, Canada, 12Division of Rheumatology, Johns Hopkins, Baltimore, MD, 13Rheumatology, Mayo Clinic, Rochester, MN, 14Rheumatology Division, Mayo Clinic, Rochester, MN

       Background/Purpose: This study aimed to describe disease-related damage in Takayasu's arteritis (TAK) and evaluate damage assessment tools using data from a large longitudinal cohort. …
  • Abstract Number: 3147 • 2015 ACR/ARHP Annual Meeting

    Inter-Provider Reliability in Scoring the Physician Global Assessment of Disease Activity Among Patients with Juvenile Idiopathic Arthritis Patients Who Met the ACR Provisional Criteria for Clinical Inactive Disease

    Janalee Taylor1, Edward H. Giannini1, Daniel Lovell2 and Esi M. Morgan DeWitt1, 1Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2PRCSG, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

    Background/Purpose: With the advent and implementation of advanced drug therapy clinical inactive disease (CID) has become an attainable target in the treatment of juvenile idiopathic…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 6
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology